172 related articles for article (PubMed ID: 7768283)
1. Beta 2-adrenoceptors mediate a reduction in endothelial permeability in vitro.
Allen MJ; Coleman RA
Eur J Pharmacol; 1995 Feb; 274(1-3):7-15. PubMed ID: 7768283
[TBL] [Abstract][Full Text] [Related]
2. Inhibition by salbutamol of the proliferation of human airway smooth muscle cells grown in culture.
Tomlinson PR; Wilson JW; Stewart AG
Br J Pharmacol; 1994 Feb; 111(2):641-7. PubMed ID: 7911722
[TBL] [Abstract][Full Text] [Related]
3. The influence of hyperthyroidism on beta-adrenoceptor-mediated relaxation of isolated small mesenteric arteries.
Zwaveling J; Winkler Prins EA; Pfaffendorf M; van Zwieten PA
Naunyn Schmiedebergs Arch Pharmacol; 1996 Mar; 353(4):438-44. PubMed ID: 8935711
[TBL] [Abstract][Full Text] [Related]
4. Beta-adrenoceptor subtypes and the opening of plasmalemmal K(+)-channels in trachealis muscle: electrophysiological and mechanical studies in guinea-pig tissue.
Cook SJ; Small RC; Berry JL; Chiu P; Downing SJ; Foster RW
Br J Pharmacol; 1993 Aug; 109(4):1140-8. PubMed ID: 8104643
[TBL] [Abstract][Full Text] [Related]
5. Effects of chronic intravenous infusions of dopexamine and isoprenaline to rats on D1-, beta 1- and beta 2-receptor-mediated responses.
Martin SW; Broadley KJ
Br J Pharmacol; 1994 Jun; 112(2):595-603. PubMed ID: 7915614
[TBL] [Abstract][Full Text] [Related]
6. Salmeterol, a long-acting beta 2-adrenoceptor agonist mediating cyclic AMP accumulation in a neuronal cell line.
McCrea KE; Hill SJ
Br J Pharmacol; 1993 Oct; 110(2):619-26. PubMed ID: 7902176
[TBL] [Abstract][Full Text] [Related]
7. Role of beta2-adrenoceptors (beta-AR), but not beta1-, beta3-AR and endothelial nitric oxide, in beta-AR-mediated relaxation of rat intrapulmonary artery.
Pourageaud F; Leblais V; Bellance N; Marthan R; Muller B
Naunyn Schmiedebergs Arch Pharmacol; 2005 Jul; 372(1):14-23. PubMed ID: 16133491
[TBL] [Abstract][Full Text] [Related]
8. Salmeterol inhibition of mediator release from human lung mast cells by beta-adrenoceptor-dependent and independent mechanisms.
Chong LK; Cooper E; Vardey CJ; Peachell PT
Br J Pharmacol; 1998 Mar; 123(5):1009-15. PubMed ID: 9535032
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characteristics of BDTI, a new isoquinoline-derived beta 2-adrenoceptor agonist, in canine trachea and rat heart.
Lin CH; Yang CM; Chen CM; Ko FN; Teng CM
Pharmacology; 1996 Jul; 53(1):19-27. PubMed ID: 8875598
[TBL] [Abstract][Full Text] [Related]
10. beta(2) and beta(3)-adrenoceptor inhibition of alpha(1)-adrenoceptor-stimulated Ca(2+) elevation in human cultured prostatic stromal cells.
Haynes JM
Eur J Pharmacol; 2007 Sep; 570(1-3):18-26. PubMed ID: 17617401
[TBL] [Abstract][Full Text] [Related]
11. Characterization of isoprenaline- and salmeterol-stimulated interactions between beta2-adrenoceptors and beta-arrestin 2 using beta-galactosidase complementation in C2C12 cells.
Carter AA; Hill SJ
J Pharmacol Exp Ther; 2005 Nov; 315(2):839-48. PubMed ID: 16051698
[TBL] [Abstract][Full Text] [Related]
12. Beta-adrenoceptor-mediated inhibition of mediator release from human peripheral blood-derived mast cells.
Wang XS; Lau HY
Clin Exp Pharmacol Physiol; 2006 Aug; 33(8):746-50. PubMed ID: 16895550
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the profiles of agonists as stimulants of the beta 3-adrenoceptor in vitro with their gastroprotective effects in the conscious rat.
Bahl AK; Clayton NM; Coates J; Martin DP; Oakley IG; Strong P; Trevethick MA
Br J Pharmacol; 1996 Feb; 117(3):580-586. PubMed ID: 8821552
[TBL] [Abstract][Full Text] [Related]
14. Salmeterol, a novel, long-acting beta 2-adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo.
Ball DI; Brittain RT; Coleman RA; Denyer LH; Jack D; Johnson M; Lunts LH; Nials AT; Sheldrick KE; Skidmore IF
Br J Pharmacol; 1991 Nov; 104(3):665-71. PubMed ID: 1686740
[TBL] [Abstract][Full Text] [Related]
15. Contractile and relaxant properties of rat-isolated pulmonary veins related to localization and histology.
Bronquard C; Maupoil V; Arbeille B; Fetissof F; Findlay I; Cosnay P; Freslon JL
Fundam Clin Pharmacol; 2007 Feb; 21(1):55-65. PubMed ID: 17227445
[TBL] [Abstract][Full Text] [Related]
16. Characterization of beta-adrenoceptor subtypes in the ferret urinary bladder in vitro and in vivo.
Takeda H; Igawa Y; Komatsu Y; Yamazaki Y; Akahane M; Nishizawa O; Ajisawa Y
Eur J Pharmacol; 2000 Sep; 403(1-2):147-55. PubMed ID: 10969156
[TBL] [Abstract][Full Text] [Related]
17. Investigations into factors determining the duration of action of the beta 2-adrenoceptor agonist, salmeterol.
Nials AT; Sumner MJ; Johnson M; Coleman RA
Br J Pharmacol; 1993 Feb; 108(2):507-15. PubMed ID: 8095419
[TBL] [Abstract][Full Text] [Related]
18. Salmeterol reduces early- and late-phase plasma leakage and leukocyte adhesion in rat airways.
Bolton PB; Lefevre P; McDonald DM
Am J Respir Crit Care Med; 1997 Apr; 155(4):1428-35. PubMed ID: 9105089
[TBL] [Abstract][Full Text] [Related]
19. Atypical adrenoceptor-mediated relaxation of canine pulmonary artery through a cAMP-dependent pathway.
Tamaoki J; Tagaya E; Isono K; Nagai A
Biochem Biophys Res Commun; 1998 Jul; 248(3):722-7. PubMed ID: 9703994
[TBL] [Abstract][Full Text] [Related]
20. Contrasting effects of hypochlorous acid and hydrogen peroxide on endothelial permeability: prevention with cAMP drugs.
Ochoa L; Waypa G; Mahoney JR; Rodriguez L; Minnear FL
Am J Respir Crit Care Med; 1997 Oct; 156(4 Pt 1):1247-55. PubMed ID: 9351629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
